tiprankstipranks
Zevra Therapeutics (ZVRA)
NASDAQ:ZVRA
US Market
Holding ZVRA?
Track your performance easily

Zevra Therapeutics (ZVRA) Technical Analysis

835 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Zevra Therapeutics’s (ZVRA) Moving Averages Convergence Divergence (MACD) indicator is -0.20, suggesting Zevra Therapeutics is a Buy.
Zevra Therapeutics’s (ZVRA) 20-Day exponential moving average is 8.29, while Zevra Therapeutics’s (ZVRA) share price is $8.05, making it a Sell.
Zevra Therapeutics’s (ZVRA) 50-Day exponential moving average is 8.41, while Zevra Therapeutics’s (ZVRA) share price is $8.05, making it a Sell.

Zevra Therapeutics (ZVRA) Pivot Points

Jan 19, 2025, 06:40 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.44
7.60
7.77
7.93
8.10
8.26
8.43
Fibonacci
7.60
7.73
7.81
7.93
8.06
8.14
8.26
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Zevra Therapeutics (ZVRA) Moving Averages

Jan 19, 2025, 06:40 AM
Period
Simple
Exponential
MA5
7.95Buy
8.02Buy
MA10
8.17Sell
8.13Sell
MA20
8.32Sell
8.29Sell
MA50
8.71Sell
8.41Sell
MA100
8.23Sell
8.08Sell
MA200
6.79Buy
7.13Buy
Zevra Therapeutics’s (ZVRA) 10-Day exponential moving average is 8.13, while Zevra Therapeutics’s (ZVRA) share price is $8.05, making it a Sell.
Zevra Therapeutics’s (ZVRA) 100-Day exponential moving average is 8.08, while Zevra Therapeutics’s (ZVRA) share price is $8.05, making it a Sell.
Zevra Therapeutics’s (ZVRA) stock price is $8.05 and Zevra Therapeutics’s (ZVRA) 50-day simple moving average is 8.71, creating a Sell signal.
Zevra Therapeutics’s (ZVRA) stock price is $8.05 and Zevra Therapeutics’s (ZVRA) 100-day simple moving average is 8.23, creating a Sell signal.
Zevra Therapeutics’s (ZVRA) stock price is $8.05 and Zevra Therapeutics’s (ZVRA) 200-day simple moving average is 6.79, creating a Buy signal.

Zevra Therapeutics (ZVRA) Technical Indicators

Jan 19, 2025, 06:40 AM
Name
Value
Implied Action
RSI (14)
43.50
Neutral
STOCH (9,6)
31.12
Neutral
STOCHRSI (14)
28.86
Neutral
MACD (12,26)
-0.20
Buy
ADX (14)
19.18
Buy
Williams %R
-67.16
Buy
CCI (14)
-96.57
Neutral
ATR (14)
0.39
-
Ultimate Oscillator
46.16
Neutral
ROC
-5.96
Sell
Zevra Therapeutics’s (ZVRA) Relative Strength Index (RSI) is 43.50, creating a Neutral signal.
Zevra Therapeutics’s (ZVRA) Trend Strength Indicator (ADX) is 19.18, creating a Buy signal.
Zevra Therapeutics’s (ZVRA) Commodity Channel Index (CCI) is -96.57, creating a Neutral signal.
Zevra Therapeutics’s (ZVRA) Price Rate of Change (ROC) is -5.96, creating a Sell signal.

FAQ

Is ZVRA a Buy, Hold, or Sell?
Based on ZVRA’s technical indicators, ZVRA is a Sell.
    What is ZVRA’s RSI (14)?
    ZVRA’s RSI (14) is 43.50, which suggests ZVRA is a Neutral.
      What is ZVRA’s MACD?
      ZVRA’s MACD is -0.20, which suggests ZVRA is a Buy.
        What is ZVRA’s 5-day moving average?
        ZVRA’s 5-day moving average is 7.95, which suggests ZVRA is a Buy.
          What is ZVRA’s 20-day moving average?
          ZVRA 20-day moving average is 8.32, which suggests ZVRA is a Sell.
            What is ZVRA’s 50-day moving average?
            ZVRA’s 50-day moving average is 8.71, which suggests ZVRA is a Sell.
              What is ZVRA’s 200-day moving average?
              ZVRA’s 200-day moving average is 6.79, which suggests ZVRA is a Buy.
                What is ZVRA’s Williams % R (14)?
                ZVRA’s Williams % R (14) is -67.16, which suggests ZVRA is a Buy.
                  What is ZVRA’s CCI (14)?
                  ZVRA’s CCI (14) is -96.57, which suggests ZVRA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis